Literature DB >> 16051596

Increased expression of Mcl-1 is required for protection against serum starvation in phosphatase and tensin homologue on chromosome 10 null mouse embryonic fibroblasts, but repression of Bim is favored in human glioblastomas.

Mark Austin1, Simon J Cook.   

Abstract

Inactivating mutations in the tumor suppressor gene phosphatase and tensin homologue on chromosome 10 (PTEN) result in elevated levels of phosphatidylinositol (3,4,5)-trisphosphate, activation of protein kinase B (PKB), and protection against apoptotic insults such as withdrawal of survival factors. Protection may arise through the inhibition of the pro-apoptotic protein Bim, which is normally repressed by a PKB-dependent mechanism. Here we show that PTEN-/- immortalized mouse embryonic fibroblasts (MEFs) exhibit elevated PKB phosphorylation and are resistant to serum withdrawal-induced death, but exhibit normal Bim expression following withdrawal of serum. In contrast, expression of Mcl-1, a prosurvival member of the Bcl-2 family, was elevated in PTEN-/- MEFs. Transient or stable overexpression of Mcl-1 in PTEN+/- MEFs conferred resistance to serum withdrawal, whereas ablating expression of Mcl-1 in PTEN-/- MEFs, using RNA interference, abolished their resistance to serum withdrawal-induced apoptosis. To determine if Mcl-1 is selected for overexpression in human tumors we examined human glioblastoma cell lines but found that loss of PTEN had no effect on Mcl-1 expression. In contrast, two of three PTEN-/- glioblastoma cell lines exhibited low expression of Bim, which was refractory to serum withdrawal. These results indicate that the resistance of PTEN-/- MEFs to serum withdrawal is largely due to the up-regulation of Mcl-1 but that loss of PTEN in tumor cell lines is more complex and may favor de-regulation of different apoptotic regulators such as Bim.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051596     DOI: 10.1074/jbc.M508187200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.

Authors:  Martin Schwickart; Xiaodong Huang; Jennie R Lill; Jinfeng Liu; Ronald Ferrando; Dorothy M French; Heather Maecker; Karen O'Rourke; Fernando Bazan; Jeffrey Eastham-Anderson; Peng Yue; David Dornan; David C S Huang; Vishva M Dixit
Journal:  Nature       Date:  2009-12-20       Impact factor: 49.962

2.  Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.

Authors:  Lindsay M Morton; Mark P Purdue; Tongzhang Zheng; Sophia S Wang; Bruce Armstrong; Yawei Zhang; Idan Menashe; Nilanjan Chatterjee; Scott Davis; Qing Lan; Claire M Vajdic; Richard K Severson; Theodore R Holford; Anne Kricker; James R Cerhan; Brian Leaderer; Andrew Grulich; Meredith Yeager; Wendy Cozen; Shelia Hoar Zahm; Stephen J Chanock; Nathaniel Rothman; Patricia Hartge
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

3.  MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.

Authors:  Mariusz L Hartman; Beata Talar; Anna Gajos-Michniewicz; Malgorzata Czyz
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

Review 4.  Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Zixiang Zhu; Xiangle Zhang; Guoqing Wang; Haixue Zheng
Journal:  Hepat Mon       Date:  2014-08-01       Impact factor: 0.660

5.  Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways.

Authors:  Mei-Ling Chan; Chia-Chun Yu; Jui-Ling Hsu; Wohn-Jenn Leu; She-Hung Chan; Lih-Ching Hsu; Shih-Ping Liu; Polina M Ivantcova; Özdemir Dogan; Stefan Bräse; Konstantin V Kudryavtsev; Jih-Hwa Guh
Journal:  Oncotarget       Date:  2017-05-20

6.  ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL.

Authors:  Katherine E Ewings; Kathryn Hadfield-Moorhouse; Ceri M Wiggins; Julie A Wickenden; Kathryn Balmanno; Rebecca Gilley; Kurt Degenhardt; Eileen White; Simon J Cook
Journal:  EMBO J       Date:  2007-05-24       Impact factor: 11.598

7.  Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase/protein kinase C-mediated upregulation of Mcl-1.

Authors:  C Rutherford; S Childs; J Ohotski; L McGlynn; M Riddick; S MacFarlane; D Tasker; S Pyne; N J Pyne; J Edwards; T M Palmer
Journal:  Cell Death Dis       Date:  2013-11-21       Impact factor: 8.469

8.  Effective Synergy of Sorafenib and Nutrient Shortage in Inducing Melanoma Cell Death through Energy Stress.

Authors:  Fernanda Antunes; Gustavo J S Pereira; Renata F Saito; Marcus V Buri; Mara Gagliardi; Claudia Bincoletto; Roger Chammas; Gian Maria Fimia; Mauro Piacentini; Marco Corazzari; Soraya Soubhi Smaili
Journal:  Cells       Date:  2020-03-06       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.